Research & Innovation
Publications

Sequoia: Results of a randomized phase iii trial of zanubrutinib versus bendamustine plus rituximab (br) in patients with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)

#2022

#Oncology Research and Treatment

PMU Authors
Richard Greil, Alan Cohen

All Authors
Richard Greil, T. Robak, K. Giannopoulos, W. Jurczak, M. Simkovic, M. Shadman, A. Osterborg, L. Laurenti, P. Walker, S. Opat, H. Chan, H. Ciepluch, M. Tani, M. Trneny, DM Brander, IW Flinn, S. Grosicki, E. Verner, JR Brown, BS Kahl, P. Ghia, J. Li, T. Tian, L. Zhou, C. Marimpietri, JC Paik, Alan Cohen, P. Hillmen, CS Tam

Journal association
Oncology Research and Treatment

Abstract

We are sorry. The full text is not available.

Latest Publication

#2025

#Abstract

Valentin Fischill-Neudeck, Antje van der Zee-Neuen, Margitta B. Beil-Hildebrand Strengthening Professional Health Literacy: A Theory-Based Approach to Empower Nursing Practice

#2025

#Original Article

Margaux Delporte, Johan Verbeeck, Isabella Brambilla, Georg Zimmermann, Geert Molenberghs, Rima Nabbout, Dravet syndrome, REGISTRY; RARE DISEASES; DRAVET SYNDROME; Natural history;

#2025

#Short comment / notes

J. Koch, K. Steinbruecker, G. Kluger, S. Knasmueller, E. Trinka Successful use of fenfluramine in drug resistant epileptic encephalopathy with spike-wave activation in sleep (EE-SWAS)- an automated EEG study, EPILEPSY; Drug Resistance; Automated spike detection;

Back to Overview

Paracelsus Medical University (PMU) Research & Innovation Publications

Sequoia: Results of a randomized phase iii trial...